Charles River Secures CDMO Deal with AAVantgarde for GMP Plasmid DNA
Charles River Laboratories International, Inc. (NYSE: CRL) and AAVantgarde today announced a contract development and manufacturing organization (CDMO) agreement to produce Good Manufacturing Practice- (GMP) plasmid DNA. The agreement involves Charles River Laboratories, a global leader in contract manufacturing, and